In February, Independence updated several policies. Recently published updates include:
- 08.00.34q: Infliximab and Related Biosimilars. Effective date, 02/15/2022.
- 00.10.18r: Modifiers for Assistant-at-Surgery Services: 80, 81, 82. Effective date, 02/14/2022.
To learn more about our Medical and Claim Payment Policy portal, visit our resource page.
For important policy information related to COVID-19, visit the Commercial and Medicare Advantage News & Announcements sections of the portal.